Choi YL - Search Results

1

Plasmonic-Magnetic Active Nanorheology for Intracellular Viscosity.

Lee S, Jung I, Lee S, Shin J, Cho E, Jung S, Ih S, Kim YG, Hong S, Choi YL, Park S. Lee S, et al. Among authors: choi yl. Nano Lett. 2023 Mar 8;23(5):2031-2038. doi: 10.1021/acs.nanolett.2c04761. Epub 2023 Jan 25. Nano Lett. 2023. PMID: 36695563

2

Analyzing Somatic Genome Rearrangements in Human Cancers by Using Whole-Exome Sequencing.

Yang L, Lee MS, Lu H, Oh DY, Kim YJ, Park D, Park G, Ren X, Bristow CA, Haseley PS, Lee S, Pantazi A, Kucherlapati R, Park WY, Scott KL, Choi YL, Park PJ. Yang L, et al. Among authors: choi yl. Am J Hum Genet. 2016 May 5;98(5):843-856. doi: 10.1016/j.ajhg.2016.03.017. Am J Hum Genet. 2016. PMID: 27153396 Free PMC article.

3

Engagement of CD99 triggers the exocytic transport of ganglioside GM1 and the reorganization of actin cytoskeleton.

Yoon SS, Jung KI, Choi YL, Choi EY, Lee IS, Park SH, Kim TJ. Yoon SS, et al. Among authors: choi ey, choi yl. FEBS Lett. 2003 Apr 10;540(1-3):217-22. doi: 10.1016/s0014-5793(03)00268-0. FEBS Lett. 2003. PMID: 12681511 Free article.

4

MHC class II engagement inhibits CD99-induced apoptosis and up-regulation of T cell receptor and MHC molecules in human thymocytes and T cell line.

Kim MK, Choi YL, Kim MK, Kim SH, Choi EY, Park WS, Bae YM, Woo SK, Park SH. Kim MK, et al. Among authors: choi ey, choi yl. FEBS Lett. 2003 Jul 10;546(2-3):379-84. doi: 10.1016/s0014-5793(03)00567-2. FEBS Lett. 2003. PMID: 12832073 Free article.

5

NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.

Lee SE, Lee MS, Bang H, Kim MY, Choi YL, Oh YL. Lee SE, et al. Among authors: choi yl. Mod Pathol. 2023 Aug;36(8):100180. doi: 10.1016/j.modpat.2023.100180. Epub 2023 Mar 30. Mod Pathol. 2023. PMID: 37003481

6

Comment on "Leveraging NGS Data to Refine Immunotherapy Response Prediction in NSCLC: PD-L1 Copy Number, Tumor Mutation Burden, and Beyond".

Hong TH, Bang YH, Joe C, Choi YL, Lee SH. Hong TH, et al. Among authors: choi yl. J Thorac Oncol. 2023 Sep;18(9):e88-e90. doi: 10.1016/j.jtho.2023.05.023. J Thorac Oncol. 2023. PMID: 37599051 No abstract available.

7

Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread.

Yoon DW, Hwang S, Hong TH, Choi YL, Kim HK, Choi YS, Kim J, Shim YM, Cho JH. Yoon DW, et al. Among authors: choi ys, choi yl. Ann Surg Oncol. 2024 Jan;31(1):201-212. doi: 10.1245/s10434-023-14373-8. Epub 2023 Oct 9. Ann Surg Oncol. 2024. PMID: 37814186

8

Clinical Significance of the Proposed Pathologic Criteria for Invasion by the International Association for the Study of Lung Cancer in Resected Nonmucinous Lung Adenocarcinoma.

Hong TH, Hwang S, Cho J, Choi YL, Han J, Lee G, Jeon YJ, Lee J, Park SY, Cho JH, Choi YS, Kim J, Shim YM, Kim HK. Hong TH, et al. Among authors: choi ys, choi yl. J Thorac Oncol. 2024 Mar;19(3):425-433. doi: 10.1016/j.jtho.2023.10.013. Epub 2023 Nov 2. J Thorac Oncol. 2024. PMID: 37924973

9

[No title available]

[No authors listed] [No authors listed] PMID: 38057627

10

Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer.

Lee H, Han J, Choi YL. Lee H, et al. Among authors: choi yl. Diagnostics (Basel). 2021 Sep 17;11(9):1695. doi: 10.3390/diagnostics11091695. Diagnostics (Basel). 2021. PMID: 34574036 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

528 results

Search Page